SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-004281
Filing Date
2020-02-12
Accepted
2020-02-12 16:58:26
Documents
1
Period of Report
2020-02-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6359
  Complete submission text file 0000899243-20-004281.txt   7680
Mailing Address 100 FIFTH AVENUE WALTHAM MA 02451
Business Address 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700
Apellis Pharmaceuticals, Inc. (Issuer) CIK: 0001492422 (see all company filings)

IRS No.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address BIOVERATIV INC. 225 SECOND AVENUE WALTHAM MA 02451
Business Address
Celona Lucia (Reporting) CIK: 0001692362 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38276 | Film No.: 20605103